Clinical trial Recruiting at 1 site Observational Ages 18 and up

Safety of sedation with non-anesthesiologist-administered propofol during interventional endoscopy

Official title: Safety of Sedation During Interventional Endoscopy - A Non-interventional Study

Run by Medical University Innsbruck · NCT07872657 · Data updated 2026-11-12

This study tests how safe and effective the use of propofol given by non-anesthesiologists is during interventional gastrointestinal endoscopy for adults.

More Sedation Complication trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorMedical University Innsbruck
Academic / other
Locations1 site (Innsbruck, Tyrol)
StatusRecruiting
StartedAugust 12, 2026
Main results expectedAugust 2031
Study endsOctober 2031
Registry record updatedOctober 13, 2026
Trial IDNCT07872657 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) undergoing interventional endoscopic procedures at Innsbruck University Hospital who consent to participate.

Probably not a fit

Patients with pre-existing respiratory or hemodynamic instability or those not undergoing interventional endoscopy may not benefit from this observational data.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study prospectively collects data on sedation practices, procedure details, and patient outcomes for interventional endoscopic procedures performed at a single center. It focuses on non-anaesthesiologist-administered propofol sedation (NAPS) during technically demanding or longer interventions and in patients with higher comorbidity. The study uses standardized NAPS protocols with trained staff, continuous monitoring, oxygen support, and immediate access to emergency response if needed. Findings may clarify safety and effectiveness of NAPS in a real-world, higher-risk population undergoing ERCP, interventional EUS, or interventional EGD. No intervention beyond routine care is performed, and data are collected observationally to describe current practice and outcomes.

Why it matters

Potential benefit: If successful, the approach could support broader use of NAPS in interventional endoscopy with maintained safety and comfort for patients.

How similar studies have gone: Previous data indicate that NAPS can be safe and effective in many endoscopic procedures, but evidence in high-risk or longer interventions is limited and this study adds real-world observations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients ≥18 years of age at time of consent
2. Ability to understand and willingness to sign and date written informed consent document
3. Patients who undergo an interventional endoscopic procedure at Innsbruck University Hospital (ERCP, interventional EUS, interventional EGD).

Exclusion Criteria:

1. Pregnancy
2. Inability to consent
3. Respiratory instability before start of intervention (SpO2 \<90 %)
4. Oxygen treatment via nasal cannula \>3 l/min before start of intervention
5. Hemodynamic instability before start of intervention (MAP \< 65 mmHg and/or vasopressor/catecholamine therapy and/or heart rate \<50/min)

Where it's running

  • Medical University of Innsbruck
    Innsbruck, Tyrol, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.